ASO visual abstract: RAS mutation status should not be used to predict outcome from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases
Authors
Bhullar, DilrajO'Dwyer, Sarah T
Wilson, Malcolm S
Saunders, Mark P
Kochhar, Rohit
Barriuso, Jorge
Aziz, Omer
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UKIssue Date
2022
Metadata
Show full item recordAbstract
NoneCitation
Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, et al. ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases. Ann Surg Oncol. 2022 Nov 20. PubMed PMID: 36404378. Epub 2022/11/21. eng.Journal
Annals of Surgical OncologyDOI
10.1245/s10434-022-12780-xPubMed ID
36404378Additional Links
https://dx.doi.org/10.1245/s10434-022-12780-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1245/s10434-022-12780-x
Scopus Count
Collections
Related articles
- RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
- Authors: Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, Aziz O
- Issue date: 2023 Feb
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
- Authors: Witmer HDD, Dhiman A, Turaga KK
- Issue date: 2023 Feb 15
- ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy-The Efficiency of Mitomycin C.
- Authors: Delhorme JB, Sauvinet G, Séverac F, Diab S, Liu D, Rohr S, Romain B, Brigand C
- Issue date: 2022 Nov
- Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
- Authors: Jeon Y, Park EJ, Lim JH, Baik SH
- Issue date: 2019 Dec 11